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P2Z Adenosine  Triphosphate  Receptor  Activity  in  Cultured  Human 
Monocyte-Derived  Macrophages 
By  Suzanne E. Hickman, Joseph El Khoury,  Steven  Greenberg,  Ira Schieren, and Samuel C. Silverstein 
The present study shows that human mononuclear phago- 
cytes express a P2Z-like purinergic membrane receptor ac- 
tivity.  Extracellular adenosine  triphosphate  (ATP) induces 
the formation  of  nonselective membrane pores in human 
mononuclear phagocytes that  allow  the entry of otherwise 
membrane impermeant fluorescent dyes  (YO-PRO-1  or  Luci- 
fer yellow) into  the  cytoplasm of these cells. The percentage 
of mononuclear phagocytes that  was  permeabilized by ATP 
increased  as  monocytes matured into macrophages.  Their 
response to ATP was inhibited by Mg2+  and oxidized ATP. 
Benzoylbenzoic-ATP  (BzBzATP)  was approximately 60% as 
effective  as  ATP  and  adenosine-5  -0-(thiophosphate) 
(ATPyS) was less than 20% as effective as  ATP  in permeabil- 
XTRACELLULAR adenosine triphosphate (ATP) me- 
diates a variety of responses in many cell types. These 
responses  include  altered  contraction  in  smooth  muscle 
cells,'  neurotransmission,2.3  release of  endothelium-derived 
relaxing factor (EDRF),4'  cell proliferation in  fibroblasts,6 
apoptosis in  thymocytes:  degranulation in  rat  mast  cells,' 
and chloride secretion in human airway epithelial cells.'  A 
distinct effect of  the free acid form of ATP (ATP-4)  is per- 
meabilization of  the plasma membranes of  several types of 
cells to molecules less than 900 daltons." 
Cellular responses to ATP are mediated by plasma mem- 
brane  nucleotide  receptors,  termed  purinergic  receptors. 
Pharmacologic studies indicate that there are at  least  three 
classes of  ATP receptors. P2UP2Y type receptors are G- 
protein-coupled  receptors that trigger release of intracellular 
Cat*  through activation of phospholipase C."."  P2X recep- 
tors directly activate ATP-ligand gated cation  channel^.'^,'^ 
P2Z  receptors  mediate  the  opening  of  large  "pores"  in 
plasma membranes, making cells permeable to ions and  me- 
tabolites up  to 900 daltons.'"," P2Z receptors are present on 
rat  mast  cells,' murine peritoneal macrophages,"and  several 
murine-transformed  cell  lines,  including  5774  and 
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izing human macrophages to YO-PRO-l  or  Lucifer  Yellow. 
Thus,  the human P2Z-like receptor differs from  its  murine 
counterpart because  BzBzATP,  ATP, and ATP+  are equally 
efficacious in permeabilizing murine macrophage-like 5774 
cells to these dyes.  UTP,  GTP,  and CTP were ineffective in 
permeabiliring human or murine macrophages  to YO-PRO-l. 
Taken together, these data indicate that  human monocyte- 
derived macrophages  express a P2Z-like activity that is phar- 
macologically distinct from  that expressed by their murine 
counterparts and that expression  of  these receptors is devel- 
opmentally regulated in human mononuclear phagocytes. 
0  1994 by The  American  Society of Hematology. 
BAC1.2F5 macrophage-like cell  Uptake of  mem- 
brane impermeant dyes such as Lucifer yellow or ethidium 
bromide in  response to ATP has been  used  to  assess P2Z 
receptor activity in  mouse peritoneal macrophages and  in 
5774 cells.'"~16~17  However, it is not  known  whether  human 
mononuclear phagocytes express P2Z receptor activity. This 
study presents evidence for the expression of P2Z-like recep- 
tor  activity  on  human  monocytes  maintained in  culture, 
which  increases  during  their  differentiation  into  macro- 
phages. 
MATERIALS AND  METHODS 
Materials.  ATP, ADP, adenosine, adenosine-5'-0-(3-thiophos- 
phate)  (ATP-?-S),  adenylyl-imidodiphosphate (AMP-PNP),  ade- 
nylyl  (P,?-methylene)-diphosphate  (AMP-PCP),  UTP,  GTP,  and 
CTP were obtained from Boehringer Mannheim Corp (Indianapolis, 
IN). Benzoylbenzoic adenosine 5"triphosphate (BzBzATP) and per- 
iodate oxidized ATP (Ox-ATP) were obtained from Sigma Chemical 
CO (St Louis, MO). Lucifer yellow and YO-PRO-l  dyes were pur- 
chased from Molecular Probes (Eugene, OR). 
Cells.  Human monocytes were isolated from leukocyte concen- 
trates (New York Blood Center, New York, NY) by  centrifugation 
over Ficoll hypaque (Sigma) as described."  The mononuclear cell 
layer was collected, washed three times in  RPMI 1640, and resus- 
pended in the same medium supplemented with 20% pooled human 
serum (Gemini, Calabasas, CA). The cells were allowed to adhere 
to tissue culture flasks (Falcon Labware, Oxnard, CA)  for 1 hour in 
the same medium at  37°C  . Nonadherent cells were washed away. 
For some experiments, the adherent cells were detached by  a brief 
incubation  with  phosphate-buffered  saline  (PBS)  containing  10 
mmoln EDTA at  4°C  followed by  tapping the side of the dish as 
described."  To obtain monocyte-derived macrophages, monocytes 
separated as above were cultured in RPMI 1640 supplemented with 
30% pooled human serum in Teflon beakers, as described."  In other 
experiments, the  adherent cells  were maintained in  tissue culture 
flasks in  RPMI media supplemented with 30% human serum and 
detached with  10 mmoVL EDTA in PBS the day  they were used. 
This method yielded greater than 90% monocytes as evidenced by 
nonspecific esterase staining and by the ability of the recovered cells 
to engulf IgG-coated sheep red blood cells (RBCs).I9  5774 cells were 
maintained in spinner flasks in Dulbecco's  medium supplemented 
with  10% bovine serum, penicillin (100 U/mL), and streptomycin 
sulfate (0.1 mg/mL). 
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Response to ATP.  Human monocytes (freshly isolated or day 1 
of  culture) or monocyte-derived macrophages (MACS) cultured in 
Teflon beakers or detached after maintenance in tissue culture flasks 
were rinsed in RPMI without serum, resuspended in RPMI, plated 
onto micro-spot slides (Shandon, Pittsburgh, PA) coated with human 
serum albumin (HSA; 1.0 mg/mL), and incubated for 1 to 2 hours 
at 37°C. Where indicated, assays were also performed in suspension. 
Cells were removed from Teflon beakers or detached from mono- 
layers, rinsed  in  RPMI, and resuspended in 0.1 mL of assay buffer. 
5774 cells were used  as  positive controls and were treated in the 
same way  as  human cells. 
Uptake of Lucifer yellow  or  YO-PRO-l.  Cells plated on HSA- 
coated slides were rinsed twice in HEPES-buffered saline (HBS; 
125  rnmol/L  NaCI,  5  mmol/L  KCl,  1 mmol/L  KH2P04, 5  mmoY 
L glucose,  l  mmol/L  NaHC03, and 20 mmol/L  HEPES, pH 7.6) 
containing 0.2 mmoVL  CaCI,  and  0.2 mmoVL MgC12. The cells 
were subsequently incubated HBS containing 5 mmoVL AV  or the 
indicated nucleotides, 5 mmol/L  probenecid, and 2 mmol/L  Lucifer 
yellow (LY) for 10 minutes at 37°C. Control cells were incubated 
in  the  same  solution without ATP.  Because LY  (457  molecular 
weight [MW]) is a substrate for the organic anion transporter present 
in  J774 cells, probenecid was included in all buffers used in the 
assay to prevent efflux of  LY.I6  For uptake studies with YO-PRO- 
1, the cells were incubated in  HBS  in  the presence or absence of  5 
mmolR. ATP or the indicated nucleotides and 10 pmol/L YO-PRO- 
1. Cells were washed three times in  HBS containing 1 mmollL CaCI, 
and  1 mmom MgCl, (and 5 mmol/L probenecid for LY studies) or 
HBS containing 1 mmoVL  CaCI,  and  l mmoK MgCl, for assays 
with YO-PRO-I. Viability was assessed by incubation for 2 minutes 
in the appropriate rinse buffer containing 1 pg/mL propidium iodide 
(PI). Uptake of  LY  or  YO-PRO-l  was  assessed by  fluorescence 
microscopy. Cells containing PI alone or PVYO-PRO-1 were classi- 
fied as nonviable and were excluded from further consideration. Data 
are expressed as % YO-PRO-l  positive = no. of  cells containing 
YO-PRO-Mota1 no. of viable cells. Cell viability exceeded 95% in 
all assays. For each experimental condition, a minimum of 200 cells 
and a maximum of  1,000 total cells were counted. 
For assays on cells in suspension, cells were rinsed as described 
and resuspended in 0.1 mL assay buffer. Buffer containing 2X con- 
centration of  dye and  10 mrnol/L ATP or the indicated nucleotides 
was  added  to  the  cells.  Subsequent incubations and  rinses were 
performed as described above. Cells were  plated  on slides and al- 
lowed  to settle for 20 minutes at 37°C before microscopic examina- 
tion. 
Flow  cyfometry.  Aliquots of  cells were removed from Teflon 
beakers and assayed in suspension in medium containing YO-PRO- 
1  and, where indicated, ATP, as described above. Flow cytometry 
was performed using an EPIC 753 flow cytometer (Coulter Electron- 
ics, Hialeah, FL) at an excitation wavelength of 488 nm  and  band 
pass filters to collect emissions between 515 and 550 nm. Nonviable 
cells positive for PI were gated out and represented less than 3% of 
the total population. Lymphocytes and cell debris were also excluded 
from the analysis with light scatter gates. Data were collected and 
analyzed using the CICERO Data Acquisition System (Cytornation, 
Inc, Ft Collins, CO). 
RESULTS AND DISCUSSION 
Development of  response to ATP in cultured human mono- 
cytes.  To optimally assay P2Z receptor activity, we used 
the  fluorescent dye  YO-PRO-l,  a  membrane-impermeant 
cation (629 daltons) whose fluorescence increases 30X upon 
binding nucleic acids?'  Unlike LY, it is not a substrate for 
organic anion transporters that clear dye from the cytoplasm, 
p 10 
0 
0  2  4  6  8  10  12  14  16 
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Fig  1.  Expression of  P22  r-tw  activity  increases  as human 
monocytes  mature  into  macrophages.  Monocytes  maintained  in 
teflon beakers were  assayed  in  suspension  at  the indicated time 
points  for  responsiveness to ATP  (5 mmol/L) by  uptake of YO-PRO- 
1. Assays were  performed  in  duplicate  on  five  different  donors;  repre- 
sentative  results from two donors  are  shown.(.)  Donor  D ATP;  (0) 
donor  D  control; (AI donor E ATP;  (A)  donor E control. 
thereby decreasing the  fluorescent signal. Therefore, YO- 
PRO-l is an  ideal candidate for the sensitive detection of 
P2Z receptor activity. Monocytes were cultured for 1 to 16 
days and were assessed for their ability to respond to ATP 
by  uptake of  YO-PRO-l  at different time points. The data 
presented represent  results  obtained  with  monocytes and 
monocyte-derived macrophages from two different donors, 
D and E (Fig 1). Nine percent to 11% of monocytes cultured 
for 1 day became permeable to YO-PRO-l during treatment 
with ATP. By  day 7 and 14 in culture, 41%  and SO%,  respec- 
tively, of the MACS became permeable to YO-PRO-l during 
ATP treatment. These results were typical of  the positive 
responses observed for monocytes and MACS from five dif- 
ferent donors. Cells from donor E exhibited half-maximal 
response by day 2, whereas donor D cells did not reach this 
point until day S. The three other donors tested in the time 
course experiments exhibited half-maximum P2Z response 
between days 4 and  S. In  a  separate set of  experiments, 
freshly harvested adherent monocytes from four donors were 
assessed  1  hour after plating for uptake of  YO-PRO-l  in 
response to ATP. P2Z receptor activity was detected in 13.3 
? 4.2% (mean ? SEM) of these cells. 
ATP mediated an increase in YO-PRO-l  uptake that re- 
sulted in a diffuse fluorescent staining of  the cytoplasm and 
intense staining of  the nucleus (Fig 2), indicating that the 
dye entered the cytoplasm directly rather than through endo- 
cytosis. 
MACS obtained from donor C incubated in YO-PRO-l 
without ATP and with ATP were analyzed by  flow cytometry 
(Fig 3). The MAC population was selected for analysis with 
light scatter gates. Cells in the MAC population represented 
35%  of  viable cells. The mean fluorescence of  cells incu- 
bated with ATP and YO-PRO-l was 6.8-fold higher than of 
cells incubated with YO-PRO-l alone. There was  no  signifi- 
cant increase in fluorescence of cells treated  with YO-PRO- 
1 alone compared with untreated cells. 
Response of human culture derived macrophages to ATP 
analogues  and  other nucleotides.  Rodent P2Z receptors re- 
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Fig 2.  Human MACs cultured 
for  12 days respond to ATP by 
uptake of YO-PRO-l. Phase con- 
trast  (b and d) and fluorescence 
(a and c) micrographs of human 
MACs treated  with 5  mmol/L 
ATP  and  YO-PRO-l.  (a) shows 
uptake  of  YO-PRO-l  by  MACs 
treated with ATP (5  mmol/L). (c) 
represents cells from  the  same 
experiment  incubated with Yo- 
Pro but  without  ATP. 
spond to BzBzATP > ATP = ATPyS > AMP-PNP >>> 
ADP/AMP.’’ We  compared the capacity of different ATP 
analogues to render 5774  cells and human MACS permeable 
to YO-PRO-l  (Fig 4). ATP, BzBzATP, and ATPyS were 
equally effective in promoting entry of YO-PRO-l  into 5774 
cells (90%  to 95%), whereas AMP-PNP was  only  35% as 
effective as ATP (Fig 4).  Adenosine, ADP, AMP-PCP, UTP, 
CTP, and GTP did not mediate uptake of YO-PRO- I  in 5774 
cells (data not shown). 
Human MACs were analyzed between  day  12 and  15  of 
culture. Forty percent to 50% of the MACs from all donors 
were permeabilized by  ATP. Similar to results obtained with 
250 r  I 
I  rh, 
Fig 3.  Flow  cytometric analysis of  cultured  human MACs  treated 
with ATP.  MACs, 14 days in culture, were  incubated in suspension 
with buffer  containing YO-PRO-l with or  without ATP, washed, and 
analyzed by  flow  cytometry. The figure  shows  overlaid  histograms 
representing  the fluorescent  intensity  profiles  obtained  for  control 
(thin  line)  and ATP treated  (thick  line) MACs. 
5774 cells, MACs did  not  take  up  YO-PRO-l  in response 
to  adenosine, ADP, AMP-PCP, UTP, CTP, or GTP (data 
not  shown). Responses to  the  analogue BzBzATP  varied 
among donors. BzBzATP was as effective as ATP in increas- 
ing  the permeability of MACs from donor C to YO-PRO-l . 
However, BzBzATP was  only  60% as effective as  ATP in 
increasing permeability of  MACs from donors D  and E to 
these dyes (Fig 4).  A striking difference between  murine  and 
human cells was seen in response  to  ATPyS. A maximum 
of  15% of MACS from donor E, 6% from donor D, and 3% 
from donor C became permeable to YO-PRO-l  in response 
to ATPyS. In contrast, 908 of 5774  cells became permeable 
h 100 
E90 
=  80 
v) 
70 
230 
a 20 
p  10 
0 
Control  ATP  BzBz  ATP  ATPrS  AMP-PNP 
Fig 4.  Effect of ATP analogs on MAC membrane permeability to 
YO-PRO-l. Responses of MACs  from  three donors (donor C assayed 
on day 10; donors  D  and  E tested  on  day 14) are compared with  the 
responses of 5774 cells. Cells were  treated with 5  mmol/L ATP or 5 
mmol/L ATP analogs as  described,  plated  onto slides, and counted 
by fluorescent microscopy. Data shown are for  a representative ex- 
periment  using cells from  three  donors assayed in duplicate (varia- 
tion among duplicates  <lo%).  (Cl) Murine J774;  I.)  donor C;  Iml 
donor D;  (0)  donor E. 
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"  DonorA  DonoCC  DonorD  DonocE 
Fig 5.  Magnesium  inhibits MAC response to ATP.  Cells from do- 
nors A,  C,  D,  and E were analyzed on days 10 through 16 of culture. 
Cells were  incubated in buffer  containing  YO-PRO-l and 5 mmol/L 
ATP,  YO-PRO-l  alone,  or YO-PRO-1/5 mmol/L ATP and 10 mmol/L 
MgCI2. Assays were  performed  twice  for  each donor in duplicate 
(variation  among  duplicates was <10%l.  Data shown are for a repre- 
sentative  experiment  and  are presented as  a percentage of cells con- 
taining YO-PRO-l. (0)  Control; (.)  5 mmol/L ATP;  ( 
to  YO-PRO-l  in  response  to  an  equal  concentration  of 
ATPyS  (5 mmoVL).  This difference may  reflect  different 
ligand affinities between the murine and human P2Z recep- 
tors. Alternatively, human P2Z receptors may  represent a 
family of ATP-  receptors that are present on different sub- 
sets of  human MACs. 
Inhibition of the ATP response by magnesium  and  oxidized 
ATP.  P2Z receptors respond to the tetra-anionic form of 
ATP  and  ATP-4, but  not  to  MgATP*-."  The  response of 
MACs to ATP was completely inhibited by  the addition of 
10 mmol/L MgC12 to the medium (Fig 5). 
Irreversible inhibition of  P2Z receptor activity in 5774 is 
seen after preincubation of these cells with oxidized ATP." 
Cells from donors A and B (day  19 of  culture) and 5774 
cells were plated onto HSA-coated slides and incubated with 
I  mmol/L oxidized ATP for 2 hours. Cells were incubated 
subsequently with  YO-PRO-l  with  or  without  5  mmoM 
ATP. Similar to 5774 cells, oxidized ATP markedly inhibited 
the subsequent response of  human MACs to ATP (Fig 6). 
These findings suggest that the receptor on MACs that re- 
sponds to ATP is a P2Z receptor. 
Uptake of  LY  in response to ATP.  Uptake of  LY  in re- 
sponse to ATP has been  used  to demonstrate P2Z receptor 
activity in 5774 cells."  We also performed experiments with 
LY to confirm that results with YO-PRO-l  are comparable 
to those obtained with LY. Forty percent of the MACs from 
donors A and B responded to ATP by uptake of LY. Uptake 
of LY by MACs in response to BzBzATP varied among the 
two donors, a phenomenon we also observed with  YO-PRO- 
1. As expected, 5774 cells became permeable to LY in re- 
sponse to ATP, ATPyS, and BzBzATP. However, less than 
20% of  human MACs became permeable to LY in response 
to ATPyS (Fig 7). MACs treated with ATP in the presence 
of  LY  exhibited diffuse cytoplasmic staining (Fig 8). This 
is similar to results obtained with 5774 cells. 
Both  murine  (5774  cells)"  and  human  (THP-I  cells)" 
macrophage-like cell lines express P2Z receptors. Exposure 
0- 
DonorA  DOMKB  J774 cells 
Fig 6.  Pretreatment  of  MACs with oxidized-ATP (Ox-ATP) inhibits 
their response to  ATP. Cells from donors A and B were analyzed on 
day 19 of culture. Cells were  incubated with  1  mmol/L ox-ATP for 2 
hours  at 37°C and then assayed for  their  ability  to respond to  ATP 
by  uptake  of YO-PRO-l. J774 cells are used for comparison. Assays 
were  performed  on  cellsfrom  five  different  donors  in duplicates (vari- 
ation 40%  among duplicates). Results are expressed for two of 
those donors as the percentage of  YO-PRO-l positive cells. I.)  No 
) ATP; (0)  control Ox-ATP; (0)  Ox-ATP/ATP. 
of  5774 cells to extracellular ATP causes release of intracel- 
lular  K+, influx of  extracellular Na+,22  and  permeabilizes 
their plasma membranes to membrane impermeant dyes."  If 
the ATP treatment is brief (<  15 minutes), these cells regain 
membrane integrity and restore intracellular ionic balance.22 
However, when  they  are incubated for prolonged periods 
(>60  minutes) in  ATP-containing medium, 5774 cells are 
lysed."  Blanchard et  a12' report that  treatment of  human 
blood monocytes and THP-l  cells with interferon y  mark- 
edly increases their sensitivity to lysis by extracellular ATP" 
and suggest that ATP's lytic effect is  mediated  by P2Z recep- 
tors. Thus, their studies suggest that  interferon y  induces 
P2Z receptor expression by  human macrophages. 
In  summary, we  have found that a small percentage of 
cn 
4 
b. 
J 
Fig 7.  Effect of ATP  analogs on MAC membrane permeability to 
LY.  Responses  of MACs from two donors (day 12 of  culture) are 
compared with the response of 5774 cells. Cells were  treated  with 5 
mmol/L ATP or 5 mmol/L analogs as described. Assays were per- 
formed  using  cells from seven different donors and  results  are shown 
for a representative experiment  for  two  of these donors. (0)  Murine 
J774;  (m) donor A;  (M)  donor B. 
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Fig 8.  Human  MACS  cultured for 12 days respond  to  ATP (5  mmoll 
LI by uptake of LY. Phase contrast (a) and fluorescence  (b)  micro- 
graphs are shown. Cells incubated in LY alone showed no uptake of 
LY (not shown). Original magnification ~1,000. 
human blood  monocytes  express  P2Z receptor-like activity. 
This P2Z-like activity is similar pharmacologically  to  that 
reported for P2Z receptors of murine macrophages, differing 
only in the human cells’ relative unresponsiveness to ATPyS 
(Fig 4 and  Blanchard  et  al”). An increasing percentage of 
human mononuclear phagocytes  express this activity as they 
mature into macrophages in  culture (Fig  l). Increased ex- 
pression of P2Z receptor activity  during differentiation of 
monocytes into macrophages suggests that this receptor, like 
the A2 adenosine receptor:4  is developmentally regulated in 
mononuclear phagocytes. 
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